Breakfast with Master 1 
Beyond the Clinical Trial Data : Impact of Real-World Experience of ZEPOSIA®
|
Room B |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Hyun Soo Kim (Chonnam National University, Korea) |
| Speaker(s) |
07:30-08:00 |
Refining Evidence-Based Strategies in UC Practice: Positioning Ozanimod Based on Real-World Experience in Korea
Dong Hyun Kim (Chonnam National University, Korea) |
Breakfast with Master 2 
Sequential Treatment in Ulcerative Colitis
|
Room C |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Sang Wook Kim (Jeonbuk National University, Korea) |
| Speaker(s) |
07:30-08:00 |
The Current Role of Filgotinib in Ulcerative Colitis
Fumihito Hirai (Fukuoka University, Japan) |
Breakfast with Master 3 
Start Strong in Ulcerative Colitis with Upadacitinib
|
Room D |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Geom-Seog Seo (Wonkwang University, Korea) |
| Speaker(s) |
07:30-07:45 |
When Time Matters in Ulcerative Colitis: Upadacitinib for Urgent Disease Control
Dong Hoon Baek (Pusan National University, Korea) |
| 07:45-08:00 |
Connecting the Dots: Evidence to Insight with Upadacitinib
Sang-Bum Kang (The Catholic University of Korea, Korea) |
Breakfast with Master 4 
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
|
Room E |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Myung Cha (Kyung Hee University, Korea) |
| Speaker(s) |
07:30-08:00 |
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
Jae Seung Soh (Hallym University, Korea) |
Breakfast with Master 5 
New and Now: Introducing Etrasimod in Ulcerative Colitis
|
Room F |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea) |
| Speaker(s) |
07:30-08:00 |
Etrasimod in Ulcerative Colitis: Clinical Evidence and Its Role in Therapy
David T. Rubin (University of Chicago, USA) |
|
Clinical Symposium 2 (ADT)
Advanced IBD Therapies: Beyond Competition, Toward Optimization
|
Room A |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA)
Dong Soo Han (Hanyang University, Korea) |
| Speaker(s) |
08:30-08:50 |
Anti-TNF Therapy: Still Standing Strong and Getting Smarter
Byong Duk Ye (University of Ulsan, Korea) |
| 08:50-09:10 |
Anti-Integrin Therapy: Ensuring Safety, Enhancing Efficacy
Vipul Jairath (Western University, Canada) |
| 09:10-09:30 |
IL-23 Inhibitors: Navigating the Expanding Choices in IBD Care
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 09:30-09:50 |
JAK Inhibitors and S1P Receptor Modulators: Emerging Contenders Beyond Biologics
Taku Kobayashi (Kitasato University, Japan) |
| 09:50-10:00 |
Discussion
|
|
Clinical Symposium 3 (Big Data)
Transforming IBD Research Through Big Data and Large Cohort Studies
|
Room B |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Gilaad G. Kaplan (University of Calgary, Canada)
Hyun-Soo Kim (Yonsei University, Korea) |
| Speaker(s) |
08:30-08:50 |
Seeing Patterns, Shaping Care: The Evolution of Big Data in IBD Research
Gilaad G. Kaplan (University of Calgary, Canada) |
| 08:50-09:10 |
Real-World Data in Action: Unlocking Insights from the Korean National Claims Data
Hyuk Yoon (Seoul National University, Korea) |
| 09:10-09:30 |
Nationwide Big Data Insights into the Epidemiology and Trends of IBD in Taiwan
Shu-Chen Wei (National Taiwan University, Taiwan) |
| 09:30-09:50 |
Toward Prevention: Expanding Perspectives on Early-Life and Environmental Risk Factors
Sun-Ho Lee (University of Toronto, Canada) |
| 09:50-10:00 |
Discussion
|
|
Translational Symposium (Microbiome/Omics)
Microbiome & Omics in IBD: Translating Science into Care
|
Room C |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea)
Takanori Kanai (Keio University, Japan) |
| Speaker(s) |
08:30-08:50 |
Microbial Signatures in IBD: Toward Precision Diagnosis and Subtype Stratification Through Multi-Layer Biomarker Discovery
Chang Kyun Lee (Kyung Hee University, Korea) |
| 08:50-09:10 |
Shaping the Gut Microbiome: Therapeutic Interventions and Clinical Implications for Inflammatory Bowel Disease
Hong Koh (Yonsei University, Korea) |
| 09:10-09:30 |
Microbiota-Mediated Intestinal Fibrosis In Crohn’s Disease : From Correlation To Causality
Ren Mao (Sun Yat-sen University, China) |
| 09:30-09:50 |
Microbes as Targets, Mediators, and Predictors of Therapy Response in IBD
Eytan Wine (The Hospital for Sick Children, Canada) |
| 09:50-10:00 |
Discussion
|
|
Clinical Symposium 4 (Colorectal Neoplasm)
Toward Precision Colorectal Cancer Screening: Integrating Risk, Tools, and Innovation
|
Room D |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Seung-Jae Myung (University of Ulsan, Korea)
Francis K.L. Chan (The Chinese University of Hong Kong, Hong Kong, China) |
| Speaker(s) |
08:30-08:50 |
FIT or Colonoscopy: What Is the Best Strategy for CRC Screening?
Wen-Feng Hsu (National Taiwan University, Taiwan) |
| 08:50-09:10 |
Personalized Screening Strategies: Beyond Age-Based CRC Guidelines
Jae Myung Cha (Kyung Hee University, Korea) |
| 09:10-09:30 |
Revolutionizing Biomarkers in Colorectal Cancer Screening
Francis K.L. Chan (The Chinese University of Hong Kong, Hong Kong, China) |
| 09:30-09:50 |
Risk-Adapted Surveillance after Polypectomy & ESD: Who, When, and How
Su Young Kim (Yonsei University, Korea) |
| 09:50-10:00 |
Discussion
|
|
AOCC Plenary Session
|
Room A |
| Date & Time
|
June 26 (Fri), 11:20-12:10 |
| Chair(s) |
Dong Il Park (Sungkyunkwan University, Korea)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
11:20-11:32 |
Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression
Jihye Park (Ewha Womans University, Korea) |
| 11:32-11:44 |
Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk
Jie Chen (The Third Xiangya Hospital of Central South University, China) |
| 11:44-11:56 |
Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility
Rirong Chen (University of Toronto, Canada) |
| 11:56-12:08 |
Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis
Tadakazu Hisamatsu (Kyorin University, Japan) |
| 12:08-12:10 |
Closing
|
Luncheon Symposium 2 
Beyond Similarity: Clinical and Real-World Insights into Ustekinumab Biosimilars
|
Room B |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Katsuyoshi Matsuoka (Toho University, Japan)
Jonghun Lee (Dong-A University, Korea) |
| Speaker(s) |
12:20-12:40 |
What is Same and Different? : Clinical Value of Ustekinumab Biosimilar
Eun Soo Kim (Kyungpook National University, Korea) |
| 12:40-13:00 |
From Evidence to Experience: Real-World Application of Ustekinumab Biosimilar in Inflammatory Bowel Disease
Sang Hyoung Park (University of Ulsan, Korea) |
Luncheon Symposium 3 
Evolving IBD Care in the Era of IL-23 Inhibitor
|
Room C |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Masayuki Saruta (Jikei University, Japan)
Young-Ho Kim (Sungkyunkwan University, Korea) |
| Speaker(s) |
12:20-12:35 |
Unmet Needs in Korean IBD Care: Evolving Expectations for New Therapeutic Options
Seong-Joon Koh (Seoul National University, Korea) |
| 12:35-13:00 |
Advancing IBD Care with Guselkumab: Insights from Clinical and Real World Evidence
David T. Rubin (University of Chicago, USA) |
|
Luncheon Symposium 4
Fast-Acting, Long-Lasting Control: Upadacitinib in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhihua Ran (Shanghai University, China)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
13:00-13:20 |
Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib
Byong Duk Ye (University of Ulsan, Korea) |
| 13:20-13:40 |
Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA) |
Luncheon Symposium 5 
A New Era in IBD Treatment: Optimizing Infliximab Therapy
|
Room C |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhanju Liu (Tongji University, China)
Yoon Tae Jeen (Korea University, Korea) |
| Speaker(s) |
13:00-13:20 |
Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 13:20-13:40 |
Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy
Sung Noh Hong (Sungkyunkwan University, Korea) |
|
Oral Presentation 1
IBD: Clinical - Treatment and Prognosis 1
|
Room A |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Shinichiro Shinzaki (Hyogo Medical University, Japan)
Beom Jae Lee (Korea University, Korea) |
| Speaker(s) |
14:30-14:38 |
Efficacy and Safety of Mirikizumab in Chinese Patients with Ulcerative Colitis Following 104 Weeks of Continuous Treatment: Results from the LUCENT-3 Open-Label Extension Study
Zhihua Ran (Shanghai University, China) |
| 14:38-14:46 |
Comparative Long-Term Outcomes of Treatment Strategies in Biologic-Naive Patients with Crohn's Disease: Anti-TNF-First vs. Ustekinumab-First
Han Hee Lee (The Catholic University of Korea, Korea) |
| 14:46-14:54 |
Real-World Comparative Effectiveness and Safety of Upadacitinib Plus Vedolizumab Versus Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study
Jiayin Yao (The Sixth Affiliated Hospital of Sun Yat-sen University, China) |
| 14:54-15:02 |
Long-Term Outcomes Following Upfront Combination Therapy with Tofacitinib and Intravenous Corticosteroids in Acute Severe Ulcerative Colitis
Arshdeep Singh (Dayanand Medical College and Hospital, India) |
| 15:02-15:10 |
Treatment Outcomes of Advanced Therapies in Patients with Refractory Ulcerative Proctitis: A Multicenter Cohort Study
Shin Ju Oh (Kyung Hee University, Korea) |
|
Oral Presentation 2
IBD: Clinical - Epidemiology
|
Room B |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Ida Hilmi (University of Malaya, Malaysia)
Kyeong Ok Kim (Yeungnam University, Korea) |
| Speaker(s) |
14:30-14:38 |
Combined Acetaldehyde Metabolism Burden Modifies IBD Susceptibility to Alcohol Consumption: A Cross-Population Multi-Ethnic Cohort Study with Validation from Integrated Genetic, Proteomics and Metabolomics Analyses
Yang Guo (The Third Xiangya Hospital of Central South University, China) |
| 14:38-14:46 |
Integrating the Environmental and Genetic Architectures of Incident IBD: Comprehensive Exposome-Wide and Genetic Analyses
Kejia Ma (The Third Xiangya Hospital of Central South University, Tianjin Medical University, China) |
| 14;46-14:54 |
Risk of Inflammatory Bowel Disease Following Hospital-Treated Infections and Modulatory Role of Host Genetics to Support a Multi-Hit Pathogenesis Model
Lintao Dan (Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, The Third Xiangya Hospital of Central South University, China) |
| 14:54-15:02 |
Association Between Medication and Cancer Incidence in Patients with Inflammatory Bowel Disease: A Population-Based, Nested Case-Control Study
Jeongkuk Seo (Chung-Ang University, Korea) |
| 15:02-15:10 |
Lonely Minds, Inflamed Guts: Metabolic and Circulating Protein Pathways Linking Social Isolation and Loneliness to Inflammatory Bowel Disease
Jianhui Zhao (Zhejiang University, Massachusetts General Hospital and Harvard Medical School, China) |
|
Oral Presentation 3
Colorectal Neoplasia: Clinical - Treatment and Prognosis
|
Room C |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Jinsu Kim (The Catholic University of Korea, Korea)
Bong Min Ko (Soonchunhyang University, Korea) |
| Speaker(s) |
14:30-14:38 |
Metachronous Advanced Neoplasia in Patients with Over 10 Adenomas: A Large Multicenter Cohort Analysis
Seung Wook Hong (Asan Medical Center, University of Ulsan College of Medicine, Korea) |
| 14:38-14:46 |
Impact of Topical Powder Application After ESD for Large Colorectal Lesions: A KASID Multicenter Randomized Controlled Trial
Yunho Jung (Soonchunhyang University, Korea) |
| 14:46-14:54 |
Clinical Significance of Close Vertical Resection Margin (0.1-1 mm) in T1 Colorectal Cancer After Endoscopic Submucosal Dissection: A Multicenter Retrospective Study
Hyung-Hoon Oh (Chonnam National University Medical School, Korea) |
| 14:54-15:02 |
Diagnostic Utility of Endoscopic Features and Endoscopic Ultrasonography for Ulcerative Colitis-Associated Neoplasia: A Retrospective Study on the Role of Endoscopic Submucosal Dissection as a Total Biopsy
Yoriaki Komeda (Kindai University Faculty of Medicine, Japan) |
| 15:02-15:10 |
Outcomes of Additional Surgery Versus Surveillance After Noncurative Endoscopic Resection of High-Risk T1 Colorectal Cancer: HASID Multicenter Study
Hyung-Hoon Oh (Chonnam National University Medical School, Korea) |
|
Oral Presentation 4
IBD: Clinical – Intestinal Ultrasound
|
Room D |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Yue Li (Peking Union Medical College Hospital, China)
Sung Wook Hwang (University of Ulsan, Korea) |
| Speaker(s) |
14:30-14:38 |
Functional Photoacoustic/Ultrasound Imaging for Assessing the Treatment Target in Ulcerative Colitis
Yue Li (Peking Union Medical College Hospital, China) |
| 14:38-14:46 |
PRISM: Integrating Intestinal Ultrasound Activity, Structural Features, and C-Reactive Protein to Predict Histological Activity in Ulcerative Colitis: A Prospective Cross-Sectional Study
Jing-Xing Li (China Medical University Hospital, Taiwan) |
| 14:46-14:54 |
Patient Perceptions and Satisfaction with Intestinal Ultrasound in Inflammatory Bowel Disease: A Multicenter Cross-Sectional Survey
Jueon Hong (Asan Medical Center, University of Ulsan College of Medicine, Korea) |
| 14:54-15:02 |
Transperineal Ultrasound for Early Identification of Corticosteroid Non-Response in Acute Severe Ulcerative Colitis (TRANSPIRE): A Prospective Pilot Study
Deloshaan Subhaharan (Gold Coast University Hospital, Bond University, Australia) |
| 15:02-15:10 |
Early Quantitative Intestinal Ultrasound Response Predicts One-Year Endoscopic Remission in Crohn’s Disease: A Prospective Treat-to-Target Cohort Study Using IBUS-SAS Score
Kayal Vizhi Nagarajan (Aster CMI Hospital, India) |
|
Oral Presentation 5
Microbiome
|
Room E |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Takanori Kanai (Keio University, Japan)
Chang Soo Eun (Hanyang University, Korea) |
| Speaker(s) |
14:30-14:38 |
Non-Toxin-Mediated Clostridioides difficile Colonization Drives Microbial Dysbiosis and Early Inflammatory Priming in IBD
Gwanghee Kim (Seoul National University Hospital, Korea) |
| 14:38-14:46 |
Microbial Metabolite Hyodeoxycholic Acid Induces Macrophage Immunometabolic Reprogramming and Alleviates Ulcerative Colitis
Yaping An (Tianjin Medical University General Hospital, China) |
| 14:46-14:54 |
Age-Related Microbial Differences in Newly Diagnosed Crohn's Disease Reveal the Distinct Enrichment of Oral-Associated Taxa in Pediatric Patients
Yun-Seok Jeong (Kyung Hee University, Korea) |
| 14:54-15:02 |
Heterogeneous Dysbiotic Pathotypes and Longitudinal Dynamics of the Gut Microbiome in Ulcerative Colitis Patients
Yeonjae Jung (CJ Bioscience, Inc., Korea) |
| 15:02-15:10 |
Pyridoxamine Depletion and Redox-Associated Microbial Restructuring in Ulcerative Colitis
Sho Tanaka (Hokkaido University Hospital, Japan) |
|
Oral Presentation 6
IBD: Pediatric & Surgery
|
Room F |
| Date & Time
|
June 26 (Fri), 14:30-15:10 |
| Chair(s) |
Yen-Hsuan Ni (National Taiwan University, Taiwan)
Eun Jung Park (University of Ulsan, Korea) |
| Speaker(s) |
14:30-14:38 |
Lymphoma and Colorectal Cancer in Pediatric-Onset Inflammatory Bowel Disease: A 15-Year Nationwide Population-Based Study in South Korea
Eun Sil Kim (Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Korea) |
| 14:38-14:46 |
Patient Perspectives on Transitional Care for Childhood-Onset Inflammatory Bowel Disease in Japan: A Multicenter Cross-Sectional Survey (TransiSCAN)
Hideki Kumagai (Jichi Medical University, Japan) |
| 14:46-14:54 |
Subcutaneous Versus Intravenous Double-Dose Infliximab for Dose Intensification in Pediatric-Onset Crohn's Disease: A Prospective Comparative Study
Tae Jong Jeong (Samsung Medical Center, Korea) |
| 14:54-15:02 |
Preoperative Food-Related Quality of Life Associated with Clinical Outcomes in Patients with Ulcerative Colitis After Ileal Pouch-Anal Anastomosis: Results from China UC Pouch Center Union
Weimin Xu (Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China, China) |
| 15:02-15:10 |
Left-Sided Ileostomy Reduces Stoma Outlet Obstruction After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Randomized Controlled Trial
Ryuichi Kuwahara (Hyogo Medical University, Japan) |
|
Oral Presentation 7
IBD: Clinical - Treatment and Prognosis 2
|
Room A |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Puo-Hsien Le (Chang Gung Memorial Hospital, Taiwan)
Jong Pil Im (Seoul National University, Korea) |
| Speaker(s) |
15:10-15:18 |
Day 3 Stool Frequency Predicts Steroid Non-Response in Korean Patients with Acute Severe Ulcerative Colitis
Sun Min Lee (Chonnam National University Hospital, Chonnam National University Medical School, Korea) |
| 15:18-15:26 |
Impact of Prior Anti-IL-12/23 Exposure on Anti-TNF Effectiveness in Crohn’s Disease: A Propensity-Weighted Cohort Study
Jiawei Zhan (The Sixth Affiliated Hospital, Sun Yat-sen University, The Sixth Affiliated Hospital, Sun Yat-sen University, The Sixth Affiliated Hospital, Sun Yat-sen University, China) |
| 15:26-15:34 |
Long-Term Outcomes of Prophylactic Scheduled Endoscopic Balloon Dilation for Crohn’s Disease-Associated Intestinal Strictures
Manabu Nagayama (Jichi Medical University, Japan) |
| 15:34-15:42 |
Integrated Blood miR-873-5p and Clinical Parameters Predict Stricturing Progression in Crohn’s Disease: A Prospective Multi-Cohort Study
Chang Liang (West China Hospital of Sichuan University, China) |
| 15:42-15:50 |
Cancer Risk with Advanced Therapies in Patients with Inflammatory Bowel Diseases: An Administrative Claims-Based Study
Soo-Kyung Park (Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Korea) |
| 15:50-16:00 |
Discussion
|
|
Oral Presentation 8
IBD: Clinical - Diagnosis and Monitoring
|
Room B |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Julajak Limsrivilai (Mahidol University, Thailand)
Eunsun Kim (Korea University, Korea) |
| Speaker(s) |
15:10-15:18 |
Performance and Treatment-Dependent Behavior of Clinically Available Biomarkers for Endoscopic Recurrence in Postoperative Crohn’s Disease
Kento Sadashima (Saga University, Saga chuo public hospital, Japan) |
| 15:18-15:26 |
Distinct IFNG-Driven Inflammation and Epithelial Metabolic Reprogramming Differentiate Intestinal Tuberculosis from Ileocecal Crohn’s Disease
Lexi Wu (Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, China) |
| 15:26-15:34 |
Clinical Significance of Small Bowel Capsule Endoscopy for Predicting Postoperative Endoscopic Recurrence in Patients with Postoperative Crohn’s Disease: J-PROSPECT Study
Motohiro Esaki (Saga University, Japan) |
| 15:34-15:42 |
Admission Factors of Steroid Refractoriness in a Prospective Cohort of Patients with Acute Severe Ulcerative Colitis (ASUC): Preliminary Analysis of a KASID Multicenter Study
Seoyoon Choi (Severance Hospital, Yonsei University College of Medicine, Korea) |
| 15:42-15:50 |
Pharmacogenetics and Metabolite-Guided Optimization of Thiopurine Therapy in Taiwanese Inflammatory Bowel Disease
Meng-Tzu Weng (National Taiwan University Hospital and College of Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Taiwan) |
| 15:50-16:00 |
Discussion
|
|
Oral Presentation 9
Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention
|
Room C |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Li-Chun Chang (National Taiwan University, Taiwan)
Ji Won Kim (Seoul National University, Korea) |
| Speaker(s) |
15:10-15:18 |
Comparison of Stool DNA Based SDC2 Methylation Testing and Repeat FIT for Advanced Colorectal Neoplasia in FIT Positive Individuals: A Multicenter Prospective Exploratory Study
Youngik Kim (Yonsei University Wonju college of Medicine, Korea) |
| 15:18-15:26 |
Comparison of Extremely Early-Onset Colorectal Cancer (EEO-CRC) Versus Extremely Late-Onset Colorectal Cancer (ELO-CRC) in Chungcheongnam-do: The Chungcheong Association for the Study of Intestinal Disease (CHASID) Multicenter Study
Doohyuck Lee (Dankook University Hospital, Korea) |
| 15:26-15:34 |
Bleeding Risk After Therapeutic Colonoscopy by Anticoagulant Type: A Retrospective Multicenter Cohort Study
Min-Jae Kim (Yonsei University College of Medicine, Korea) |
| 15:34-15:42 |
Acceptance of Family-Based Interventions for Colorectal Cancer Screening: Assessing Adult Children as Digital Care Partners
Jeongkuk Seo (Chung-Ang University, Korea) |
| 15:42-15:50 |
Combined Application of Modified Colorectal Cancer Risk Scoring and Fecal Immunochemical Testing for Early Detection of Colorectal Cancer
Temuulen Tsedensodnom (Mongolian National University of Medical Sciences, Mongolia) |
| 15:50-16:00 |
Discussion
|
|
Oral Presentation 10
AI
|
Room D |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Wee Chian Lim (Tan Tock Seng Hospital, Singapore)
Young-Eun Joo (Chonnam National University, Korea) |
| Speaker(s) |
15:10-15:18 |
Latent-Space Multimodal Deep Learning for Predicting Disease-Behavior Progression in Long-Standing Crohn’s Disease: An Interpretable and Clinically Deployable AI Framework
Hanqiao Dai (Peking Union Medical College Hospital- Chinese Academy Medical Sciences & Peking Union Medical College, China) |
| 15:18-15:26 |
Deep Learning of Pre-Treatment Spatial Pathological Signatures Predicts Long-Term Endoscopic Healing to Vedolizumab in Ulcerative Colitis: A Multicenter Study
Yadi Lan (Tianjin Medical University General Hospital, China) |
| 15:26-15:34 |
Development and Validation of a Computed-Tomography Enterography Radiomic Approach for Quantification of Small-Bowel Damage in Crohn’s Disease
Linwei Wang (Zhongshan Hospital of Xiamen University, China) |
| 15:34-15:42 |
Multimodal Deep Learning for Predicting High-Risk Pathological Features in Superficial Colorectal Cancer
Junghun Han (Yonsei University Wonju College of Medicine, Korea) |
| 15:42-15:50 |
Evaluating Multimodal Large Language Model Pipelines for Colonic Polyp Detection and Boundary Estimation
Eue Young Kim (Seoul National University Hospital, Seoul National University College of Medicine, Korea) |
| 15:50-16:00 |
Discussion
|
|
Oral Presentation 11
Basic/Translational
|
Room E |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Seong-Joon Koh (Seoul National University, Korea)
Jun Hwan Yoo (CHA University, Korea) |
| Speaker(s) |
15:10-15:18 |
Endothelial PIEZO1 Activates the HIF1A-Driven Lactate Shuttle That Reprograms Macrophage Transmigration and Polarization in IBD
Chang Liang (West China Hospital of Sichuan University, China) |
| 15:18-15:26 |
Granzyme K CD8+ T Cells with Tissue-Resident Features Promote Intestinal Inflammation in Patients with Crohn's Disease
Yoonho Lee (Brain Korea 21 project, Asan Medical Center, University of Ulsan College of Medicine, Korea) |
| 15:26-15:34 |
Anti-IL-12/23p40 Is Associated with Superior Anti-Fibrotic Effects Compared with Anti-TNF and Anti-alpha4beta7
Han Na Kim (Kyungpook National University, Korea) |
| 15:34-15:42 |
Neutrophil-Secreted Grancalcin Reprograms Mesenchymal Stem Cell Fate via HSPA5 to Drive Pathologic Creeping Fat in Crohn's Disease
Fengfei Wu (Nanfang Hospital, Southern Medical University, China) |
| 15:42-15:50 |
Suppression of CPT1A-mediated Fatty Acid β-Oxidation Promotes Fibroblast Activation and Intestinal Fibrosis in Crohn's Disease
Zhiyin Feng (The First Affiliated Hospital of Sun Yat-Sen University, China) |
| 15:50-16:00 |
Discussion
|
|
Oral Presentation 12
Small Bowel Disease
|
Room F |
| Date & Time
|
June 26 (Fri), 15:10-16:00 |
| Chair(s) |
Jose D. Sollano (University of Santo Tomas, Philippines)
Seong Ran Jeon (Soonchunhyang University, Korea) |
| Speaker(s) |
15:10-15:18 |
Synergistic Effects of Partial Enteral Nutrition Combined with Ustekinumab in Induction and Maintenance Therapy for Crohn’s Disease: Real-World Experience from a Multicentre Cohort
Yuan Zeng (The Sixth Affiliated Hospital, Sun Yat-sen University, The Sixth Affiliated Hospital, Sun Yat-sen University, China) |
| 15:18-15:26 |
Aligning Patient and Planetary Health: Planetary Health Diet Adherence and Inflammatory Bowel Disease Prognosis Across Western and Eastern Cohorts
Haiting Shu (The Third Xiangya Hospital of Central South University, China) |
| 15:26-15:34 |
Barriers and Facilitators to Crohn’s Disease Exclusion Diet Adoption in Malaysian Adults with Crohn’s Disease
Nazihah Wafi (University of Malaya, Malaysia) |
| 15:34-15:42 |
Small Bowel Rebleeding After Capsule Endoscopy: Effects of Device-Assisted Enteroscopy on Small Bowel Rebleeding Probability, Risk Factors, and Mortality in a Nationwide Big Data Cohort
Joo Hye Song (Konkuk University, Korea) |
| 15:42-15:50 |
Life-Course Psychosocial Stress and Incident Irritable Bowel Syndrome
Jianhui Zhao (Zhejiang University, Massachusetts General Hospital and Harvard Medical School, China) |
| 15:50-16:00 |
Discussion
|
|
IMKASID for Young Researchers
|
Room G |
| Date & Time
|
June 26 (Fri), 14:30-16:00 |
| Chair(s) |
Jeong-Sik Byeon (University of Ulsan, Korea)
Young Sun Kim (Seoul National University, Korea) |
| Speaker(s) |
14:30-14:45 |
Optimizing IBD Outcomes Across the Lifespan: Differential Positioning of Biologics and Small Molecules from Pediatrics to Adulthood
Jung Hyun Noh (Seoul National University, Korea) |
| 14:45-15:00 |
Clinical Characteristics and Surgical Outcomes of Adolescent-Onset Crohn’s Disease Compared with Pediatric- and Adult-Onset Disease A Nationwide Multicenter Retrospective Cohort Study (CONNECT Study Group)
Soojin Gang (Ewha Womans University, Korea)
Minjee Kim (Sungkyunkwan University, Korea) |
| 15:00-15:15 |
Tailoring Colorectal Cancer Screening for Older Adults: Strategies Beyond Routine Colonoscopy
Geunhyuk Choi (Soonchunhyang University, Korea) |
| 15:15-15:30 |
New Colorectal Cancer Screening – Moving Beyond Fit
Yeojin Lee (University of Ulsan, Korea) |
| 15:30-15:45 |
Artificial Intelligence in Capsule Endoscopy: Current Landscape and Future Perspectives
Kwangmin Joo (Dong-A University, Korea) |
| 15:45-16:00 |
Gut Microbiome in Inflammatory Bowel Disease: From Dysbiosis to Personalized Therapy
Hee Won Kwon (Kyungpook National University, Korea) |
|
Meet the Expert 1
Advancing IBD Care with Subcutaneous Infliximab
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Redefining IBD Treatment Strategies: The Role of Subcutaneous Infliximab
Rupert Leong (University of Sydney, Australia) |
|
Meet the Expert 2
Emerging Treatment in Crohn’s Disease with Fistula
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Clinical Efficacy and Real World Experience with Guselkumab in CD with Fistula
Vipul Jairath (Western University, Canada) |
|
Clinical Symposium 5 (Pregnancy & Obesity)
Global IBD Perspectives: Pregnancy and Obesity across East and West
|
Room A |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
You Sun Kim (Hallym University, Korea)
Joana Torres (University of Lisbon, Portugal) |
| Speaker(s) |
16:20-16:40 |
Pregnancy in IBD: Essential Knowledge for Clinicians and Patients
Joana Torres (University of Lisbon, Portugal) |
| 16:40-17:00 |
IBD and Pregnancy in East Asia: Regional Insights and Clinical Experience
Eun Mi Song (Ewha Womans University, Korea) |
| 17:00-17:20 |
Epidemiology and Pathophysiology of Obesity and IBD: Asian Perspectives
Jaeyoung Chun (Yonsei University, Korea) |
| 17:20-17:40 |
Optimizing Medical Therapy in IBD Patients with Obesity
Siddharth Singh (Mayo Clinic Arizona, USA) |
| 17:40-17:50 |
Discussion
|
|
Clinical Symposium 6 (Small Bowel & Nutrition)
Current Perspective on Diet and Nutrition in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Dong Kyung Chang (Sungkyunkwan University, Korea)
Tadakazu Hisamatzu (Kyorin University, Japan) |
| Speaker(s) |
16:20-16:40 |
Dietary and Environmental Risk Factors in IBD: Theory and Practice
Rupa Banerjee (AIG Hospitals, India) |
| 16:40-17:00 |
Impact of Diet and Urban Environment in Crohn’s Disease: Diet-omics Cohort Study
Rui Feng (Sun Yat-Sen University, China) |
| 17:00-17:20 |
Tools and Challenges of Dietary Assessment in IBD and Colorectal Diseases: Lessons From Clinical Experiences
Yun Jeong Lim (Dongguk university, Korea) |
| 17:20-17:40 |
Recent Advances in Enteral Nutrition for IBD: Beyond The Walls
Robert V Bryant (The Queen Elizabeth Hospital, Australia) |
| 17:40-17:50 |
Discussion
|
|
KASID-GEST Joint Symposium
Current Status and Future Perspectives in Intestinal Diseases
|
Room C |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Shu-Chen Wei (National Taiwan University, Taiwan)
Jeong-Sik Byeon (University of Ulsan, Korea) |
| Speaker(s) |
16:20-16:40 |
Current Status and Treatment Trends of IBD in Taiwan
Tzung-Jiun Tsai (Kaohsiung Veterans General Hospital, Taiwan) |
| 16:40-17:00 |
Current Status and Treatment Trends of IBD in Korea
Joo Hye Song (Konkuk University, Korea) |
| 17:00-17:20 |
Current Status and Treatment Trends of Colorectal Cancer in Taiwan
Li-Chun Chang (National Taiwan University, Taiwan) |
| 17:20-17:40 |
Current Status and Treatment Trends of Colorectal Neoplasms in Korea
Seong-Jung Kim (Chosun University, Korea) |
| 17:40-17:50 |
Discussion
|
|
Clinical Symposium 7 (AOCC for Pediatricians)
Bridging Evidence and Practice in Pediatric IBD
|
Room D |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Eytan Wine (The Hospital for Sick Children, Canada)
Kyung Mo Kim (University of Ulsan, Korea) |
| Speaker(s) |
16:20-16:40 |
Early-Onset Pediatric IBD: From Immune Pathways to Clinical Application
Takashi Ishige (Gunma University, Japan) |
| 16:40-17:00 |
Pediatric Ulcerative Colitis: Key Updates from the Latest ECCO–ESPGHAN Guidelines
Eytan Wine (The Hospital for Sick Children, Canada) |
| 17:00-17:20 |
Real-World Practice of Nutritional Therapy in Pediatric Crohn’s Disease
Hyeji Lim (Yonsei University, Korea) |
| 17:20-17:40 |
Practical Precision Medicine in Pediatric IBD: Advanced Therapies in Real-World Settings
Mi Jin Kim (Sungkyunkwan University, Korea) |
| 17:40-17:50 |
Discussion
|
